Achira
Focus: Achira is a pre-revenue biotech focused on atomistic foundation simulation models to accelerate drug discovery, headquartered in San Francisco with a specialized focus on neurology.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Total Funding
$33M
Open Jobs
7
Should You Work at Achira?
AI assessmentHigh-risk, high-optionality bet suited for computational scientists comfortable with pre-clinical stage risk and undefined exit timeline.
Why Work Here
- Join a computational drug discovery platform at the intersection of AI and structural biology with clear technical differentiation in atomistic simulation.
- Early-stage opportunity with 100% hiring concentration in Data Science (5 of 7 roles), indicating core technical team building phase.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Achira
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.